GlassScriptPhysician profile
Elena Bortan
NPI 1922216191
$2,562.80
in general payments reported to CMS, 2019-2025
17 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $40.52 · 2021: $165 · 2022: $14.00 · 2023: $997 · 2024: $593 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,782 · Travel and Lodging: $292 · Education: $3.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,781.67 |
| Travel and Lodging | $291.61 |
| Education | $3.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $853.13 | 2021-2024 | Percept PC Brainsense |
| Abbvie INC. | $324.07 | 2019-2025 | |
| Abbott Laboratories | $296.43 | 2023-2025 | Infinity |
| Mdd US Operations, LLC | $273.26 | 2024-2025 | Gocovri |
| Acadia Pharmaceuticals INC | $147.76 | 2024 | Nuplazid |
| Boston Scientific Corporation | $107.72 | 2019 | |
| Amneal Pharmaceuticals LLC | $99.95 | 2023-2024 | Rytary, Crexont |
| Medtronic USA, INC. | $88.25 | 2019 | |
| Allergan, INC. | $81.25 | 2019-2021 | |
| Kyowa Kirin, INC. | $70.18 | 2024-2025 | Nourianz |
| Neurocrine Biosciences, INC. | $57.70 | 2021 | |
| Merz Pharmaceuticals, LLC | $53.89 | 2023-2024 | Inbrija, Xeomin |
| Supernus Pharmaceuticals, INC. | $37.63 | 2025 | Qelbree |
| Ge Healthcare | $26.56 | 2020 | |
| Horizon Therapeutics Plc | $17.06 | 2023 | Uplizna |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $14.00 | 2022 | |
| Sunovion Pharmaceuticals INC. | $13.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Bortan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.